Skip to main content
SpringerLink
Log in
Book cover

Positron Emission Tomography pp 183–193Cite as

Lymphoproliferative Diseases

  • Chapter
  • First Online:

  • 2422 Accesses

Abstract

Currently it is accepted to distinguish among lymphoproliferative diseases the groupings of lymphomas, leukoses and lymphomas/leukoses (Gantsev 2004). Malignant neoplasms originating from the elements of lymph nodes or extranodal lymphatic tissue are qualified as lymphomas, while leukoses are tumors from peripheric blood cells, and the group of lymphomas-leukoses consists of diseases with both signs. Neoplasms of plasma cells, including myelomatosis and plasmocytoma, are not presently qualified as lymphomas.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Suggested Readings

  • Gantsev ShH, Ruchkin VN, Frolov VY et al (2002) Cancer and geological formations. Bashkir Health, Ufa, p 48

    Google Scholar 

  • Garin AM, Khlebnikov A, Habagari DS (1992) Handbook of anticancer therapy. Moscow (in Russian)

    Google Scholar 

References

  • Aboizied MM, Crawford ES, Nabi HA (2005) 18F-FDG imaging pitfalls and artifacts. Nucl Med Technol 33:145–155

    Google Scholar 

  • Barnngton SF, O’Doherty MJ (2003) Limitations of PET for imaging lymphoma. Nucl Med Mol Imaging 30:117–127

    Article  Google Scholar 

  • Beal KP, Yeung HW, Yahalom J (2005) FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 16:473–480

    Article  PubMed  CAS  Google Scholar 

  • Blum RH, Seymour JF, Wirth A et al (2003) Freguent impact of [18F] fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin’s lymphoma. Clin Lymphoma 4:43–49

    Article  PubMed  Google Scholar 

  • Buchmann I, Reinhardt M, Elsner K et al (2001) 2-(Fluorine-18) fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. Cancer 91:889–899

    Article  PubMed  CAS  Google Scholar 

  • Carr R, Barrington SF, Madan B et al (1998) Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91:3340–3346

    PubMed  CAS  Google Scholar 

  • Elstrom R, Guan L, Baker G et al (2003) Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 101:3875–3876

    Article  PubMed  CAS  Google Scholar 

  • Fnedberg JW, Fischman A, Neuberg D et al (2004) FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow up of patients with de novo Hodgkin lymphoma a blinded comparison. Leuk Lymphoma 45:85–92

    Article  Google Scholar 

  • Fuster D, Chiang S, Andreadis C et al (2006) Can [18F] fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma? Nucl Med Common 27:11–15

    Article  Google Scholar 

  • Gambhir SS, Czernin J, Schwimmer J et al (2001) A tabulated summery of the FDG-PET literature. J Nucl Med 42:1S–93S

    PubMed  CAS  Google Scholar 

  • Gantsev ShH (2004) Oncology: a textbook for medical students. Moscow, (in Russian)

    Google Scholar 

  • Gershanovich ML, Borisov VI, Sidorenko YS et al (1995) Current possibilities and perspectives of drug therapy in oncology. Vopr Onkol 41(2):116–124 (in Russian)

    PubMed  CAS  Google Scholar 

  • Isasi CR, Blaufox MD (2005) A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer 104:1066–1074

    Article  PubMed  Google Scholar 

  • Jerusalem G, Beguin Y (2002) Does positron emission tomography have a role in routine clinical practice in patients with Hodgkin’s disease? Clin Lymphoma 3:125–126

    Article  PubMed  Google Scholar 

  • Jerusalem G, Warland V, Najjar F et al (1999) Whole-body 18F-FDG-PET for the evaluation of patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Nucl Med Commun 20:13–30

    Article  PubMed  CAS  Google Scholar 

  • Jerusalem G, Hustinx R, Begum Y, Fillet G (2005a) Evalution of therapy for lymphoma. Semin Nucl Med 35:186–196

    Article  PubMed  Google Scholar 

  • Jerusalem G, Hustinx R, Begum Y, Fillet G (2005b) Positron emission tomography imaging for lymphoma. Curr Opin Oncol 17:441–445

    Article  PubMed  Google Scholar 

  • Juweid ME, Wiseman GA, Vose JM et al (2005) Response assessment of aggressive non Hodgkin’s lymphoma by integrated International Workshop criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Med Oncol 23:4652–4661

    Article  Google Scholar 

  • Kostakoglu L, Coleman M, Leonard JP et al (2002) PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin’s disease. J Nucl Med 43:1018–1027

    PubMed  Google Scholar 

  • Mikhael NG, Timothy AR, Odoherty MJ et al (2000) 18 FDG-PET as a prognostic indicator in the treatment of aggressive non Hodgkin’s lymphoma – comparison with CT. Leuk Lymphoma 39:543–553

    Article  Google Scholar 

  • Mikhael NG, Hutchings M, Fields PA et al (2005) FDG-PET after two to three cycles of chemotherapy predicts progression free and overall survival in high-grade non-Hodgkin’s lymphoma. Ann Oncol 16:1514–1523

    Article  Google Scholar 

  • Moog F, Bangetter M, Diedrichs CG et al (1997) Lymphoma: role of whole-body 2-deoxy-2-[F18] fluoro-D-glucose (FDG) PET in nodal staging. Radiology 203:795–800

    PubMed  CAS  Google Scholar 

  • Moog F, Kotzerke J, Reske N (1999) FDG-PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1410

    PubMed  CAS  Google Scholar 

  • Naumann R, Beuthien-Baumann B, Reiss A et al (2004) Substantial impact of FDG-PET imaging on the therapy decision in patients with Hodgkin’s disease. Ann Oncol 90:620–625

    CAS  Google Scholar 

  • Pakos EE, Fotopoulos AD, Ioannidis JP (2005) 18F-FDG-PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta analysis. J Nucl Med 46:958–963

    PubMed  Google Scholar 

  • Panizo C, Perez Salazar M, Bendandi M et al (2004) Positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual Hodgkin’s disease mediastinal masses. Leuk Lymphoma 45:1829–1833

    Article  PubMed  Google Scholar 

  • Partridge S, Timothy A, O’Doherty MJ et al (2000) 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin’s disease: influence on patient management in a single institution. Ann Oncol 11:1273–1279

    Article  PubMed  CAS  Google Scholar 

  • Rigacci L, Castagnoli A, Dim C et al (2005) 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin’s lymphoma long-term results. Oncol Rep 14:1209–1214

    PubMed  CAS  Google Scholar 

  • Schiepers C, Filmont JE, Czernin J (2003) PET for staging of Hodgkin’s disease and non Hodgkin’s lymphoma. J Nucl Med Mol Imaging 30:82–88

    Article  Google Scholar 

  • Schoder H, Noy A, Gonen M et al (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol 23:4643–4651

    Article  PubMed  Google Scholar 

  • Talbot JN, Haioun C, Rain JD et al (2001) [18F]-FDG positron imaging in clinical management of lymphoma patients. Crit Rev Oncol Hematol 38:193–221

    Article  PubMed  CAS  Google Scholar 

  • Tonzuka T, Nakamura F, Kanno T et al (2004) Early therapy monitoring with FDG PET in aggressive non Hodgkin’s lymphoma and Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 31:22–28

    Article  Google Scholar 

  • Vazhenin AV, Voronin MI, Vaganov NV et al (2003) Radiodiagnosis and radiotherapy: a textbook for medical students, residents and interns. Moscow (in Russian)

    Google Scholar 

  • Vinnicombe SJ, Rezneck RH (2003) Computerised tomography in the staging of Hodgkin’s disease and non Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 30:42–55

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Russian Research Center for Radiology and Surgery, St. Petersburg, Russia

    Anatoliy Granov

  2. Department of Radiology and Nuclear Medicine, Russian Research Center for Radiology, St. Petersburg, Russia

    Leonid Tiutin

  3. Department of Nuclear Medicine Division of Radiology, Medical University Graz, Graz, Austria

    Thomas Schwarz M.D.

Authors
  1. Anatoliy Granov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonid Tiutin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Schwarz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Russian Research Center for Radiology an, Pesochny, ul. Leningradskaya 70, St. Petersburg, 197758, Russia

    Anatoliy Granov

  2. , Dept. of Radiology and Nuclear Medicine, Russian Research Center for Radiology, Pesochny, ul. Leningradskaya 70, St. Petersburg, 197758, Russia

    Leonid Tiutin

  3. , Klinische Abt. für Nuklearmedizin, Universitätsklinik für Radiologie, Auenbruggerplatz 9, Graz, Austria

    Thomas Schwarz

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Granov, A., Tiutin, L., Schwarz, T. (2013). Lymphoproliferative Diseases. In: Granov, A., Tiutin, L., Schwarz, T. (eds) Positron Emission Tomography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21120-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21120-1_16

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21119-5

  • Online ISBN: 978-3-642-21120-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation